BELLUS Health (TSE:BLU) shares fall below the 50-day moving average of $19.48

The share price of BELLUS Health Inc. (TSE:BLU – Get a Free Report) fell below its fifty-day moving average during trading on Monday. The stock has a fifty-day moving average of $19.48 and traded as low as $19.24. BELLUS Health shares last traded at C$19.48, with a volume of 28,666 shares traded.

BELLUS Health Price Performance

The company has a 50-day moving average of $19.48. The company has a current ratio of 33.42, a quick ratio of 16.40 and a debt-to-equity ratio of 0.32. The company has a market capitalization of C$2.47 billion, a price-to-earnings ratio of -20.29 and a beta of -0.28.

BELLUS Health company profile

(Get a free report)

BELLUS Health Inc, a clinical-stage biopharmaceutical company, is developing therapies for the treatment of refractory chronic cough (RCC) and other indications of cough hypersensitivity. Its lead product candidate is BLU-5937, a P2X3 receptor antagonist, which is in a Phase II clinical trial for the treatment of RCC and chronic itch.

Read further

Receive daily news and reviews for BELLUS Health – Enter your email address below to receive a daily summary of the latest news and analyst ratings for BELLUS Health and related companies with’s FREE daily email newsletter.

Back To Top